I won't touch this with 10 feet pole now seeing they are shorting it
I will revisit at 0.35-0.4 where it was
Most biotech lose all the games of pump once data is bad..
Market is not happy with data, you won't see such huge collapse if data was good
Those who look for HOME RUN in pennyland eventually BECOME HOMELESS
Be Careful out there
Recent KTRA News
- Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm • PR Newswire (US) • 04/05/2024 05:09:00 PM
- Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement • PR Newswire (US) • 04/03/2024 11:00:00 AM
- Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab • PR Newswire (US) • 03/27/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:59:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:00:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:00:10 PM
- Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 02/14/2024 09:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:05:27 PM
- Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer • PR Newswire (US) • 02/12/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:10:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/18/2023 09:05:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:15:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 02:10:19 PM
- Kintara Therapeutics Announces Review of Strategic Alternatives • PR Newswire (US) • 12/07/2023 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 02:10:08 PM
- Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement • PR Newswire (US) • 12/05/2023 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 12:55:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:15:23 PM
- Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 11/13/2023 09:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:05:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 12:10:08 PM
- Kintara Therapeutics Announces Preliminary Topline Results From GBM AGILE Study • PR Newswire (US) • 10/31/2023 12:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/27/2023 08:05:48 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/24/2023 08:43:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:06:50 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM